(n = 15); and then in 2017 (n = 48), after a 2-year period with no cases diagnosed. Since 2010, a total of 81 (CF=17%) fatalities occurred among WNND cases, with a median age of 80 (49-95) years. Cases were recorded, in both urban and rural areas, in half (37/74) of the Regional Units (NUT-3 level), in all 13 Regions. In 2011, the virus dispersed southwards to newly affected Regional Units, and in the following years cases were recorded both in previously affected and in new areas, during each transmission season. In 2017, cases were also recorded for the first time in the two last-previously non-affected-Regions of the country. Sequences from PCR-positive samples revealed WNV lineage 2, with high genetic similarity to the 2010 strain.
Background. Preexisting DENV antibodies may have a cross-reactivity against ZIKV. A recent primate study suggested that prior DENV infection does not adversely impact subsequent ZIKV disease and might be protective. This study aimed to evaluate the relation between a Dengue Fever (DF) outbreak in 2016 and the prevalence of ZIKV infection in Rio Grande do Norte (RN), a Brazilian northeast state endemic for arboviruses.
Methods. A cross-sectional analysis was conducted using data obtained through the RN Department of Health from January 2015 to April 2017. We analyzed the epidemiological behavior of DF and Zika Virus Disease in RN (last three summers).
Results. From January to March in 2015 March in , 2016 March in , and 2017 , and 1,677 DF suspected cases, respectively. The number of confirmed DF cases in 2015, 2016, and 2017 were 523, 7,599, and 204, respectively . Regarding ZIKV infection, the number of suspected cases of between January to April during 2016 and 2017 were 3,486 and 86, respectively. The number of confirmed ZIKV infection in 2016 and 2017 were 97 and 0, respectively. Adding up the total cases of ZIKV infection which occurred during 2015 and 2016, we obtain a total of 14,584 (8,743 + 5,841) . This number represents less than 0.5% of the RN population (3,409 million).
Conclusion. This epidemiological evidence support our hypothesis that the DF outbreak in 2016 has contributed to the decrease of 97.53% (86/3,486) in the prevalence of ZIKV infection (suspected cases) in 2017. It may be explained by preexisting DENV antibodies might partially neutralize ZIKV infection through serologic cross-reactivity. It supports the results found on the recent primate study. In addition, our findings contradict the theory (based on in vitro experiments only) that previous immunity to DENV causes an enhancement of the immunological response in individuals exposed to ZIKV. Given the fact of the total suspected ZIKV cases in 2015 and 2016 represent less than 0.5% of the RN population, we cannot state that there are fewer Zika cases in 2017 because the population has been previously immunized. These data are highly relevant from a public health standpoint given that regions which experienced ZIKV outbreak in Brazil are endemic for DF and suggests that DENV vaccines might also offer some protection against ZIKV infection.
Disclosures.All authors: No reported disclosures. Methods. VIDOH staff called 291 mothers, connected with 148, and scheduled 114 appointments. The clinic set-up included: two intake, four neurology, threeophthalmology, one audiology, one developmental, child life team, and two exit stations. Infants received comprehensive neurology, developmental, ophthalmology, and audiology examinations and were connected to resources such as Infant and Toddlers: Early Intervention services, Act Early: Learn the Signs, Disability Rights of the Virgin Islands and local specialized physicians. A data abstraction team of six reviewed charts for accuracy and abstracted data into both the US Zika pregnancy registry forms and the local Zika database.
Leveraging Partnerships to
Results. The visiting specialists evaluated 88 infants; 65 (73.9%) in St. Thomas and 23 (26.1%) in St. Croix, 84 (73.7%) appointments and four walk-ins. There were 53 (60.2%) males and 35 (39.8%) females. Seven (7.9%) infants were 0-2 months, 18 (20.5%) were 3-6 months, 38 (43.2%) were 7-12 months, 25 (28.4%) were 13-24 months. Fiftyeight (65.9%) infants were referred for further follow-up; 35 (60.3%) to an audiologist, 20 (34.5%) to Infants and Toddlers program, 11 (19%) to a neurologist, 10 (17.2%) to an ophthalmologist, 8 (13.8%) to a developmental pediatrician, 8 (13.8%) for physical therapy, four (6.9%) for speech therapy, three(5.2%) for neuroimaging, three(5.2%) for occupational therapy, and 2 (3.4%) to an otorhinolaryngologists.
Conclusion. Probable hearing loss was the chief finding in many of the infants screened. Further evaluation on these infants has been recommended based on clinical guidance for infants exposed to Zika virus infection. This can help to identify the types of hearing loss associated with Zika infection in utero.
Disclosures.All authors: No reported disclosures. Background. Zika Virus infection (ZIKV) during pregnancy has been linked with fetal microcephaly. The purpose of this study was to describe the microcephaly cases that occurred during the ZIKV epidemic in Dominican Republic (DR) in 2016-2017.
Infant Microcephaly During the Zika Virus Epidemic in Dominican
Methods. We analyzed surveillance data from DR National System of Epidemiologic Surveillance. The Intergrowth 21st Newborn size application tool was used to determine percentiles and z scores for head circumference (HC) by gestational age. We used linear and log-binomial regression for multivariate analyses of HC Z-score and severe microcephaly (HC of 0 percentile vs. >0 percentile), respectively.
Results. Eighty-five infants were born with microcephaly due to ZIKV from June 2016 to March 2017. ZIKV IgM was positive in all 85 infants. Infants were 55% male and half were from the metropolitan area. Most (89%) received inpatient care and 13% had respiratory distress. One infant had a meningocele and one died soon after birth. Nearly half (47%) of mothers were known to have ZIKV and 45 (53%) mothers recalled having ZIKV symptoms during their pregnancy. Among these 45 women, the most common
